Effect of PCV and VCV on Extravascular Lung Water
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03514706 |
|
Recruitment Status :
Completed
First Posted : May 2, 2018
Last Update Posted : March 5, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Extravascular Lung Water | Diagnostic Test: volume controlled ventilation Diagnostic Test: pressure controlled ventilation | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 50 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Adult patients scheduled for elective thoracic surgery with one lung ventilation will be included in the study. Patients will be randomly allocated into one of two groups: Group V: will receive volume controlled mechanical ventilation. Group P: will receive pressure controlled mechanical ventilation. |
| Masking: | Single (Investigator) |
| Masking Description: | Lung ultrasound will be done by an investigator blinded to group allocation |
| Primary Purpose: | Screening |
| Official Title: | The Ultrasound Estimation of Extravascular Lung Water in Volume Controlled Versus Pressure Controlled Ventilation After One Lung Ventilation in Thoracoscopic Surgery. A Comparative Study |
| Actual Study Start Date : | March 1, 2018 |
| Actual Primary Completion Date : | January 1, 2019 |
| Actual Study Completion Date : | March 1, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Volume controlled ventilation
Group V: Patients will receive volume controlled mechanical ventilation. (Vt 7ml/kg ideal body weight).
|
Diagnostic Test: volume controlled ventilation
Lung ultrasound (LUS) will be performed with a 2-4 MHz phased array probe. Patients will be scanned in supine position by a recording 5 seconds videos. LUS will be assessed for the presence of B lines. The sum of lung comets produces a score reflecting the extent of lung water accumulation. LUS will be obtained by scanning 12-rib interspaces. The sum of B-lines on each scanning site yields a score from 0 to 36 Other Name: LUS |
|
Experimental: Pressure controlled ventilation
Group P: Patients will receive pressure controlled mechanical ventilation. (to achieve Vt 7 ml/kg ideal body weight, Pmax 30 cmH2O)
|
Diagnostic Test: pressure controlled ventilation
Lung ultrasound (LUS) will be performed with a 2-4 MHz phased array probe. Patients will be scanned in supine position by a recording 5 seconds videos. LUS will be assessed for the presence of B lines. The sum of lung comets produces a score reflecting the extent of lung water accumulation. LUS will be obtained by scanning 12-rib interspaces. The sum of B-lines on each scanning site yields a score from 0 to 36 Other Name: LUS |
- Lung ultrasound score [ Time Frame: change of lung ultrasound scores introperatively during double lung and single lung ventilation and after 2 hours postoperatively compared to baseline scores before anesthesia induction ]The sum of B lines reflects the extent of lung water accumulation. The lung ultrasound score(LUS) will be obtained by scanning 12-rib interspaces. The dependent lung will be divided into six areas: two anterior areas, two lateral areas, and two posterior areas. The anterior chest wall (zone 1) will be delineated from the parasternal to the anterior axillary line and will be divided into upper and lower halves, from the clavicle to the third intercostal space and from the third to the diaphragm. The lateral area (zone 2) will be delineated from the anterior to the posterior axillary line and was divided into upper and basal halves. The posterior area (zone 3) will be considered as the zone beyond the posterior axillary line. The sum of B-lines on each scanning site (0: absence; 1: B7 lines: multiple B-lines 7 mm apart; 2: B3 lines: multiple B 3 mm apart; 3: consolidation) yields a score from 0 to 36(10) score for the ventilated lung is only from 0-18.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult patients aged (18-60 years), undergoing elective thoracoscopic surgery with one lung ventilation
Exclusion Criteria:
- Emergency surgeries.
- Left Ventricular ejection fraction less than 40%.
- Any patient known to have pulmonary hypertension
- Patients with preoperative congestive heart failure, cardiogenic shock, preoperative pulmonary edema
- Hepatic patients (liver functions double the upper reference range)
- Morbid obesity (BMI > 40).
- Renally impaired patients with creatinine more than 2 mg/dl.
- Any patient with respiratory dysfunction (FEV1<60% of the expected).
- Any patient with previous thoracic surgery.
- One lung ventilation more than 2 hours
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03514706
| Egypt | |
| Kasr Al-Ainy faculty of medicine. Cairo University | |
| Cairo, Egypt, 11516 | |
| Principal Investigator: | Hisham Hosny, MD | Kasr Al-Ainy Faculty of Medicine |
| Responsible Party: | Hisham Hosny, Associate professor, Cairo University |
| ClinicalTrials.gov Identifier: | NCT03514706 |
| Other Study ID Numbers: |
AnesthN-8-2018 |
| First Posted: | May 2, 2018 Key Record Dates |
| Last Update Posted: | March 5, 2019 |
| Last Verified: | March 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Extravascular lung water one lung ventilation volume controlled ventilation pressure controlled ventilation |

